Tuberculous peritonitis after treatment with adalimumab.
We present a case of tuberculous peritonitis in a woman with rheumatoid arthritis (RA), treated with adalimumab, and we review the association between anti-tumour necrosis factor (anti-TNF) therapy and tuberculosis. There have been only 2 case reports of peritoneal tuberculosis associated with anti-TNF and only 1 with adalimumab.
Antolín
Jose
J
Internal Medicine, San Carlos Clinic Hospital, Madrid, Spain. pepe.antolin@gmail.com
Azahara
Marcos
M
Hernández
Clara
C
Blanco
Margarita
M
Mao
Laura
L
Cigüenza
Ramon
R
D000068879:Adalimumab; D000368:Aged; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014395:Peritonitis, Tuberculous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D000904:Antibiotics, Antitubercular; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D011718:Pyrazinamide; D000068879:Adalimumab; D007538:Isoniazid; D012293:Rifampin